Test Code LAB57 Carcinoembryonic Antigen (CEA), Serum
Intended Use
The Access CEA assay is a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of Carcinoembryonic Antigen (CEA) levels in human serum, using the Access Immunoassay Systems. CEA measured by the Access Immunoassay Systems is used as an aid in the management of cancer patients in whom changing CEA concentrations have been observed.
Methodology
Immunoenzymatic Assay
Performing Laboratory
RCH
Specimen Requirements
Required: Serum
Container: Plain, red-top or gold, serum gel tube
Specimen Volume: 1.0 mL (minimum volume 0.1 mL)
Collection Instructions: Forward promptly.
Specimen Stability
Ambient: 8 hours
Refrigerated: 48 hours
Frozen (-20°C): >48 hours
Day(s) Test Set Up
Monday through Sunday
Test Classification and CPT Coding
82378